Moderna Inc
NASDAQ:MRNA
Products, Other Pre-Announcement
Moderna Announces Submission Of Initial Data To U.S. FDA For Its Covid-19 Vaccine Booster
Published: 09/01/2021 20:37 GMT
Moderna Inc (MRNA) - Moderna Announces Submission of Initial Data to U.S. FDA for Its Covid-19 Vaccine Booster.
Moderna Announces Submission of Initial Data to U.S. FDA for Its Covid-19 Vaccine Booster.
Moderna Inc - Mrna-1273 at 50 Μg Dose Level Induced Robust Antibody Responses of More Than 40x Against Delta Variant (b.
1.617.
2).
Moderna Inc - Expects to Submit Data to Ema and Other Regulatory Authorities Around World in Coming Days for Its Covid-19 Vaccine Booster.
Moderna Announces Submission of Initial Data to U.S. FDA for Its Covid-19 Vaccine Booster.
Moderna Inc - Mrna-1273 at 50 Μg Dose Level Induced Robust Antibody Responses of More Than 40x Against Delta Variant (b.
1.617.
2).
Moderna Inc - Expects to Submit Data to Ema and Other Regulatory Authorities Around World in Coming Days for Its Covid-19 Vaccine Booster.